TORONTO and GLIL YAM, Israel , Aug. 6, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC ) (the " Company ", " IMCannabis ", or " IMC "), a leading medical cannabis company with operations in Israel and Germany , will report operational and financial results for the second quarter 2024 ended June 30, 2024 , on Wednesday, August 14, 2024 , before the market opens.
The Company will host a zoom web conference on the same day at 9:00am ET to discuss the results, followed by a question-and-answer session for the investment community. Investors are invited to register by clicking here . All relevant information will be sent upon registration.
If you are unable to join us live, a recording of the call will be available on our website at https://investors.imcannabis.com/ within 24 hours after the call.
Link for the to register for the zoom call: https://us02web.zoom.us/webinar/register/WN_W9nYbBB4R7CREuqN9dGOag About IM Cannabis Corp.
IMC (Nasdaq: IMCC ) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany , two of the largest medical cannabis markets. The Company has focused its resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany . The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain.
With an unwavering commitment to responsible growth and compliance with the st.